SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-296316
Filing Date
2019-11-20
Accepted
2019-11-20 11:55:33
Documents
3
Group Members
CHARLES E. GALECHARLES E. GALE FIDELITY ROLLOVER IRACHARLES HENRY ROSE 2001 TRUSTEVELYN P. ROSEEVELYN P. ROSE FIDELITY SEP IRAEVELYN POTTER ROSE SURVIVOR'S TRUSTJOHN WILLIAM ROSE 2002 TRUSTMONTROSE INVESTMENTS GP, LLCMONTROSE INVESTMENTS I, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d836820dsc13da.htm SC 13D/A 206982
2 EX-7.4 d836820dex74.htm EX-7.4 14641
3 EX-7.5 d836820dex75.htm EX-7.5 15151
  Complete submission text file 0001193125-19-296316.txt   238382
Mailing Address 300 CRESCENT COURT SUITE 700 DALLAS TX 75201
Business Address
ROSE WILLIAM (Filed by) CIK: 0001193284 (see all company filings)

Type: SC 13D/A

Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Subject) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89517 | Film No.: 191233471
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences